Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
The International AIDS Vaccine Initiative Posts $150,000 Challenge on InnoCentive in Search of New Approaches to AIDS Vaccine Design
January 7th, 2009
InnoCentive, Inc., the global innovation marketplace, announced that the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world, has posted a $150,000 Challenge on InnoCentive's Web site. The Challenge seeks proposals for and a sample of the protein that will provide researchers with new avenues for furthering HIV vaccine design and development. Specifically, the Challenge calls for the design of a protein – or trimer – that mimics the part of the HIV envelope that is first visible to the body's host defenses. In...
Source: Vaccine Weekly (2009-01-07)
|
